Cabozantinib + Rifampin Interaction
Moderateinteraction on record
Description
Strong CYP3A4 inducer that decreased cabozantinib exposure by 77%. Avoid chronic co-administration or increase COMETRIQ dosage if unavoidable.
Mechanism
CYP3A4 induction
Source: NLP:cabozantinib